Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 11 of 11 for “"CDKL5 Deficiency Disorder"”.
-
Presynaptic dysfunction in CDKL5 deficiency disorder
Cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder (CDD) is a monogenic developmental and epileptic encephalopathy with onset in early infancy that is caused by mutations in the CDKL5 gene. CDD patients often exhibit profound neurodevelopmental delay, visual and motor deficits, and …
-
Proteasome Modulation for the Treatment of CDKL5 Deficiency Disorder
CDKL5 Deficiency Disorder (CDD) is an X-linked neurodevelopmental disorder and epileptic encephalopathy caused by mutations in Cyclin-dependent kinase-like 5 (CDKL5). Numerous unique CDKL5 mutations have been identified, with the majority occurring within the region of the gene that encodes the …
-
Synaptic, Circuit, And Behavioral Insights Into Cdkl5 Deficiency Disorder
… in the X-linked cyclin-dependent kinase-like 5 (CDKL5) gene cause a severe neurodevelopmental disorder named CDKL5 deficiency disorder (CDD). In humans, CDD is characterized by early-onset epilepsy, severe intellectual disability, autistic features, and various comorbidities. Mice lacking …
-
Temporal And Molecular Insights Into The Pathophysiology Of Cdkl5 Deficiency Disorder
CDKL5 deficiency disorder (CDD) is a severe, neurodevelopmental disorder associated with lesions in the X-linked cyclin-dependent kinase-like 5 (CDKL5) gene. Despite the simple genetic etiology of CDD its pathophysiology remains poorly understood, and the treatability of specific CDD symptoms is …
-
CONTEXTUAL AND DEVELOPMENTAL INSIGHTS INTO SIGNALING PATHWAY ALTERATIONS IN CDKL5 DEFICIENCY DISORDER
CDKL5 deficiency disorder (CDD) is a debilitating neurodevelopmental disorder and one of the most common forms of genetic epilepsy. CDD is known to be caused by mutations in the X-linked cyclin-dependent kinase-like 5 (CDKL5) gene, however the pathophysiology remains unclear. Here, we use mouse …
-
Ampa Receptor Dysregulation And Therapeutic Interventions In A Mouse Model Of Cdkl5 Deficiency Disorder
CDKL5 Deficiency Disorder (CDD) is a rare disease that presents as a set of neurological deficits including early-life epilepsy, intellectual disability, and autistic-like behaviors. It results from pathogenic mutations in the gene for cyclin-dependent kinase-like 5 (CDKL5), a protein that is …
-
Social behaviours in rat models of autism
Neurodevelopmental disorders (NDDs) manifest during early childhood and have deleterious effects on development, leading to lifelong conditions affecting attention, cognition, motor abilities, communication and social domains, often alongside physical ailments such as gastrointestinal issues and …
-
Generation and validation of mouse models of neurodevelopmental disorders
To unravel the pathogenesis of neurodevelopmental disorders, disease models are required which have predictive validity for human outcomes. Furthermore, experimental paradigms are required which give access to relevant phenotypes. De novo heterozygous missense mutations in EEF1A2 have been …
-
Cellular and circuit excitability in rodent models of neurodevelopmental disorders
Autism spectrum disorders and intellectual disabilities (ASD/ID) are estimated to a↵ect approximately 3-5% of the population. Genetic factors constitute a major risk factor in ASD/ID, accounting for 40 to 50% of cases, with monogenic forms of syndromic ASD representing 5% of cases. Many of the …
-
Mechanisms of presynaptic dysfunction in rodent models of epilepsy
… activity. Notably, a variety of epileptic disorders have been attributed to mutations in genes encoding for presynaptic proteins. Of these, mutations in both the human Cyclin Dependent Kinase Like 5 (CDKL5) and Synaptic Vesicle Glycoprotein 2A (SV2A) genes have been reported to culminate in …